Clinical Trials Browser

Phase 4 × OTHER_GOV × Nivolumab × Clear all

NCT04331626 2020-04-02

Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung